Dementia And Alzheimer's

 That's why we at Merz take Dementia And Alzheimer's very serious, so that we can offer you the best drug for each treatment and therapy you need.Memantine.com | Dementia And Alzheimer's: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Dementia And Alzheimer's Merz GmbHDementia And Alzheimer's Merz - our research for your health. Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. Dementia And Alzheimer's: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Dementia And Alzheimer's is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Dementia And Alzheimer's now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Dementia And Alzheimer's very serious, so that we can offer you the best drug for each treatment and therapy you need. Dementia And Alzheimer's and Merz means research for your health. High-quality products and information about Dementia And Alzheimer's can be found on our website. Visit us online and learn everything about Dementia And Alzheimer's from one of Germany's leading health care companies. Our contribution to Dementia And Alzheimer's: read here what we can do for you. Further links: Axura: Information for professionals.>>>  Dementia And Alzheimer's Merz GmbH Memantine.com | Dementia And Alzheimer's: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Visit us online and learn everything about Dementia And Alzheimer's from one of Germany's leading health care companies. Dementia And Alzheimer's Merz GmbHDementia And Alzheimer's Inform yourself about Dementia And Alzheimer's now.Memantine.com | Dementia And Alzheimer's: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . Other franchise covered by Merz are hepatology, metabolic diseases and dermatology. Calcium enters into the cell, and through secondary processes, the signal is recognized. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. In the course of the disease, the chronic release of glutamate and the permanently increased intracellular calcium concentration leads to neuronal degeneration (neurodegeneration). Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. The pathological, sustained release of low glutamate concentrations, from both neurones and surrounding glia cells, also displaces magnesium from the NMDA receptor channel. During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Calcium enters into the cell, and through secondary processes, the signal is recognized. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . The excitatory effect of chronically released glutamate effects the degeneration of cortical and subcortical neurons, thus leading to the occurrence of dementia symptoms. vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. The safety of the combination therapy was investigated in a postmarketing surveillance study. Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . The 2 large studies have shown positive effects of memantine in mild to moderate cases of vascular dementia. Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's . Dementia And Alzheimer's Merz - our research for your health. Dementia And Alzheimer's
Merz Logo
Merz
Merz visuell
 


This page has moved permanently. You will be redirected to our new website. If not, your browser does not support JavaScript. Please activate JavaScript. Details below.

>> Start >>


Microsoft Internet Explorer (version 5.0 and later)
Open the menu "Tools", choose "Internet options" and go to the tab "Security". Then click on the button "Custom Level" and scroll down to the setting "Active Scripting" and select "Activate".


Netscape Navigator (version 4.7 and later)
In the "Edit"-menu choose the item "preferences". Open the item "Extended" and activate the control button "activate JavaScript".

 
Merz GmbH Dementia And Alzheimer'sDementia And Alzheimer's Merz - our research for your health. Dementia And Alzheimer's Dementia And Alzheimer's Merz - our research for your health. Dementia And Alzheimer's and Merz means research for your health.